Chuck Royce's CMPX Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 1.62 M shares of Compass Therapeutics, Inc. (CMPX) worth $8.57 M, representing 0.08% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in CMPX, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 1.33 M shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Compass Therapeutics (CMPX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Compass Therapeutics (CMPX) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.33 M | Add 466.39% | 1.62 M | $5.29 |
| Q4 2025 | +285,988 | New Buy | 285,988 | $5.37 |
Chuck Royce's Compass Therapeutics Investment FAQs
Chuck Royce first purchased Compass Therapeutics, Inc. (CMPX) in Q4 2025, acquiring 285,988 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Compass Therapeutics, Inc. (CMPX) for 2 quarters since Q4 2025.
Chuck Royce's largest addition to Compass Therapeutics, Inc. (CMPX) was in Q1 2026, adding 1,619,798 shares worth $8.57 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 1,619,798 shares of Compass Therapeutics, Inc. (CMPX), valued at approximately $8.57 M.
As of the Q1 2026 filing, Compass Therapeutics, Inc. (CMPX) represents approximately 0.08% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Compass Therapeutics, Inc. (CMPX) was 1,619,798 shares, as reported at the end of Q1 2026.